Determining the degree of Adherence to treatment in Inflammatory Bowel Disease patients
Gastroenterology and Hepatology from Bed to Bench,
Vol. 11 No. Supplement 1 (2018),
11 Azar 2018
,
Page s39-s44
https://doi.org/10.22037/ghfbb.v0i0.1541
Abstract
Aim: Since the inflammatory bowel disease (IBD) is a disorder which requires continuous drug intake to induce and maintain the remission phase, finding the barriers for low adherent group, may improve the disease phase and quality of life in those patients.
Background: IBD is defined as a chronic immune disorder with unpredictable flares. The common treatment of these diseases can be effective for inducing and maintaining remission courses. Therefore the use of long-term medication therapy is the crucial key to prevent surgery and complications in patients with IBD.
Methods: Morisky Medication Adherence Scales (MMAS) is used for detecting level of adherence to the medicines for 137 patients with IBD. Demographic and clinical data are recorded for all patients and quality of life has been evaluated by Short-Form 36 questionnaire in 55 patients.
Results: Demographic and clinical features showed no correlation with the degree of adherence. The MMAS-8 score in the low adherent group significantly different than that in the medium and high adherer group. No relation was found statistically between level of adherence and mental or physical sates (p value=0.17, 1.2) and total quality of life (p value=0.22) in patients with IBD.
Conclusion: Designing smart reminder and the physician’s explain about adverse effects and beneficial of medicines may be effective to confront with forgetfulness and feeling comfort with treatment. Improve a strategy in order to regular measurement of adherence to medication, provides enough information about stop taking medication.
Keywords: Inflammatory bowel disease, Ulcerative colitis, Crohn’s disease, Adherence, Quality of life.
(Please cite as: Balaii H, Olyanasab Narab S, Khanabadi B, Alsadat Anaraki F, Shahrokh SH. Determining the degree of adherence to treatment in inflammatory bowel disease patients. Gastroenterol Hepatol Bed Bench 2018;11(Suppl. 1):S39-S44).
- Inflammatory bowel disease
- Ulcerative Colitis
- Crohn’s disease
- adherence
- quality of life
How to Cite
References
Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GE, Cohen A, et al. Patient nonadherence to medication in inflammatory bowel disease. AJG 2003;98:1535-44.
Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. AJM 2003;114:39-43.
Dadaei T, Safapoor MH, Asadzadeh Aghdaei H, Balaii H, Pourhoseingholi MA, Naderi N, et al. Effect of vitamin D3 supplementation on TNF-α serum level and disease activity index in Iranian IBD patients. Gastroenterol Hepatol Bed Bench. 2015;8:49-55.
Higgins PD, Rubin D, Kaulback K, Schoenfield P, Kane S. Systematic review: impact of non‐adherence to 5‐aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment pharmacol Ther 2009;29:247-57.
Taghipour N, Molaei M, Mosaffa N, Rostami-Nejad M, Asadzadeh Aghdaei H, Anissian A, et al. An experimental model of colitis induced by dextran sulfate sodium from acute progresses to chronicity in C57BL/6: correlation between conditions of mice and the environment. Gastroenterol Hepatol Bed Bench. 2016;9:45-52.
Kane SV, Sumner M, Solomon D, Jenkins M. Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database. Digest Dis Sci 2011;56:3463-70.
Ingerski LM, Baldassano RN, Denson LA, Hommel KA. Barriers to oral medication adherence for adolescents with inflammatory bowel disease. J Pediatr Psychol 2009;35:683-91.
Taghipour N, Aghdaei HA, Haghighi A, Mossafa N, Tabaei SJ, Rostami-Nejad M. Potential treatment of inflammatory bowel disease: a review of helminths therapy. Gastroenterol Hepatol Bed Bench. 2014;7:9-16.
Rostami Nejad M, Ishaq S, Al Dulaimi D, Zali MR, Rostami K. The role of infectious mediators and gut microbiome in the pathogenesis of celiac disease. Arch Iran Med. 2015;18:244-49.
Trindade AJ, Ehrlich A, Kornbluth A, Ullman TA. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflamm Bowel Dis 2011;17:599-604.
Bermejo F, Román AL-S, Algaba A, Guerra I, Valer P, García-Garzón S, et al. Factors that modify therapy adherence in patients with inflammatory bowel disease☆. J Crohns Colitis 2010;4:422-6.
Greenley RN, Kunz JH, Biank V, Martinez A, Miranda A, Noe J, et al. Identifying youth nonadherence in clinical settings: data-based recommendations for children and adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2011;18:1254-9.
Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nature clinical practice Gastroenterol Hepatol 2006;3:390-407.
Tiao DK, Chan W, Jeganathan J, Chan JT, Perry J, Selinger CP, et al. Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis 2017;23:1257-61.
Bhatt J, Patil S, Joshi A, Abraham P, Desai D. Self-reported treatment adherence in inflammatory bowel disease in Indian patients. Indian J Gastroenterol 2009;28:143-6.
Chan W, Chen A, Tiao D, Selinger C, Leong R. Medication adherence in inflammatory bowel disease. Intest Res 2017;15:434-45.
Robinson A. Improving adherence to medication in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2008;27 s1:9-14.
San Román AL, Bermejo F, Carrera E, Pérez-Abad M, Boixeda D. Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig 2005;97:249-57.
Lennard-Jones J. Classification of inflammatory bowel disease. Scan Journal Gastroentero 1989;24 sup170:2-6.
Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian Version of the 8-Item Morisky Medication Adherence Scale (MMAS-8) in Iranian Hypertensive Patients. Glob J Health Sci 2014;7:173-83.
Krousel-Wood M, Islam T, Webber LS, Re R, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in hypertensive seniors. Am J Manag care 2009;15:59.
Kane SV, Robinson A. understanding adherence to medication in ulcerative colitis–innovative thinking and evolving concepts. Aliment Pharmacol Ther 2010;32:1051-8.
Sewitch MJ, Abrahamowicz M, Bitton A, Daly D, Wild GE, Cohen A, et al. Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. Am J gastroenterol 2001;96:1470-9.
Karbalaei R, Piran M, Rezaei-Tavirani M, Asadzadeh-Aghdaei H, Heidari MH. A systems biology analysis protein-protein interaction of NASH and IBD based on comprehensive gene information. Gastroenterol Hepatol Bed Bench. 2017;10:194-201.
Červený P, Bortlík M, Kuběna A, Vlček J, Lakatos PL, Lukáš M. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis 2007;13:1244-9.
Kim SB, Kim KO, Jang BI, Kim ES, Cho KB, Park KS, et al. Patients' beliefs and attitudes about their treatment for inflammatory bowel disease in Korea. J Gastroenterol Hepatol 2016;31:575-80.
Bucci C, Zingone F, Tammaro S, Iovino P, Santonicola A, Ciacci C. Factors predicting the adherence to the therapy of Italian IBD patients. Gastroenterol Res Pract 2017;2017.
Ghadir MR, Bagheri M, Vahedi H, Daryani NE, Malekzadeh R, Hormati A, et al. Nonadherence to Medication in Inflammatory Bowel Disease: Rate and Reasons. Middle East J Dig Dis 2016;8:116.
Burgess SW, Sly PD, Morawska A, Devadason SG. Assessing adherence and factors associated with adherence in young children with asthma. Respirology 2008;13:559-63.
Marhefka SL, Koenig LJ, Allison S, Bachanas P, Bulterys M, Bettica L, et al. Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications. AIDS Patient Care STDS 2008;22:637-47.
Zelikovsky N, Schast AP. Eliciting accurate reports of adherence in a clinical interview: development of the Medical Adherence Measure. Pediatr Nurs 2008;34.
- Abstract Viewed: 124 times
- PDF Downloaded: 90 times